As fast-paced medical scientific advancements continue, Europe needs to be ready for them. The upcoming revision of the EU’s pharmaceutical legislation is a once in a generational opportunity not only to create a framework for today’s medicines, but also to build a launchpad for tomorrow’s innovation.

This Reuters Events session, in partnership with EFPIA, will provide the platform for this important discussion. A panel of policymakers, regulators, and industry representatives will debate how to forge a future-proofed regulatory framework and why this will stimulate R&D and accelerate patient access across the Union.

Join this session to hear:

· Why having a future-proof regulatory framework matters and how it could revolutionise the way we conduct     research & development of medicines.

· How the EU regulatory framework is performing compared to other regions: its strengths and areas for the greatest    potential improvement.

· Concrete solutions to make a world-leading Europe regulatory system, and the resources needed to deliver this.